Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Single Arm, Open-label, Phase IV Clinical Trial to Evaluate the Safety and Efficacy of MEDITOXIN® in Children With Cerebral Palsy

NCT01256021 is registered in ClinicalTrials.gov with Medy-Tox as lead sponsor.

NCT NCT01256021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01256021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Single Arm, Open-label, Phase IV Clinical Trial to Evaluate the Safety and Efficacy of MEDITOXIN® in Children With Cerebral Palsy
Lead sponsor
Medy-Tox
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2010
Completion date
May 31, 2011
Enrollment
212 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

muscle spasticity